Abstract
Delivery of plasmid DNA by nanoparticles improves the DNA bioavailability, for instance in intramuscular administration, by localizing the DNA in the muscle tissue. Extracellular sustained release of the DNA may lead to more prolonged transgene expression. The present study describes a novel controlled gene delivery system based on a water soluble and biodegradable polyphosphoester, poly(2-aminoethyl propylene phosphate) (PPE-EA). The polymer degraded in PBS at 37°C through the cleavage of the backbone phosphate bonds, and it was synthesized with a relative high molecular weight to ensure a suitable hydrolytic stability as a gene carrier. The tissue response and cytotoxicity study demonstrated a better tissue compatibility of PPE-EA in mouse muscle compared with commonly used polyethylenimine and poly-L-lysine. PPE-EA condensed DNA efficiently and protected DNA from nuclease and serum degradation. Sustained release of plasmid was achieved from PPE-EA/DNA complexes as a result of PPE-EA degradation. The DNA release profiles appear to be predominantly controlled by carrier degradation and the release rate of plasmid could be adjusted by varying the charge ratio of PPE-EA to DNA. At an N/P (amino to phosphate groups) ratio of 1, a 46% burst was observed for the first day, followed by about 4% release per day (24 μg DNA/day/mg of complex) for 12 days. Higher charge ratios reduced both the DNA release rate and the burst effect. The released DNA retained its structural and functional integrity. Intramuscular injection of PPE-EA-p43-LacZ complexes at N/P ratios of 0.5 and 1 resulted in enhanced β-galactosidase expression in anterior tibialis muscle in Balb/c mice, as compared with naked DNA injections. Similarly, PPE-EA/IFNα2b DNA complexes generated an increased systemic level of interferon-α2b in mouse serum following intramuscular injection, as compared with naked DNA injection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cohen H et al. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles Gene Therapy 2000 7: 1896–1905
Tinsley-Bown AM et al. Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery J Control Rel 2000 66: 229–241
Mathiowitz E et al. Biologically erodable microsphere as potential oral drug delivery system Nature 1997 386: 410–414
Mao H-Q et al. Biodegradable poly(phosphoester)s Mathiowitz E (eds); Encyclopedia of Controlled Drug Delivery John Wiley 2001 pp 45–60
Singh M, Briones M, Ott G . O'Hagan D. Cationic microparticles: a potent delivery system for DNA vaccines Proc Natl Acad Sci USA 2000 97: 811–816
Klugherz BD et al. Gene delivery from a DNA controlled-release stent in porcine coronary arteries Nat Biotechnol 2000 18: 1181–1184
Wang J, Mao HQ, Leong KW . A novel biodegradable gene carrier based on polyphosphoester J Am Chem Soc 2001 123: 9480–9481
Koh JJ et al. Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice Gene Therapy 2000 7: 2099–2104
Lim YB et al. Biodegradable polyester, poly[alpha-(4-aminobutyl)-L-glycolic acid], as a non-toxic gene carrier Pharm Res 2000 17: 811–816
Lim YB, Choi YH, Park JS . A self-destroying polycationic polymer: biodegradable poly(4-hydroxy-L-proline ester) J Am Chem Soc 1999 121: 5633–5639
Putnam D, Langer R . Poly(4-hydroxy-L-proline ester): low-temperature polycondensation and plasmid DNA complexation Macromolecules 1999 32: 3658–3662
Wen J, Kiang T, Mao HQ, Leong KW . Biodegradable poly(phosphoester) for oral gene delivery Proc 28th Intern Symp Control Rel Bioact Mater 2001 28: 1209–1210
Wang S et al. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes Mol Ther 2001 3: 658–664
Radwanski E et al. Pharmacokinetics of interferon alpha-2b in healthy volunteers J Clin Pharmacol 1987 27: 432–435
Acknowledgements
This work is supported by Agency for Science, Technology and Research, Singapore and Johns Hopkins Singapore Biomedical Center.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, J., Zhang, PC., Mao, HQ. et al. Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrier. Gene Ther 9, 1254–1261 (2002). https://doi.org/10.1038/sj.gt.3301794
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301794
Keywords
This article is cited by
-
Fabrication and characterization of DNA-loaded zein nanospheres
Journal of Nanobiotechnology (2012)
-
Breaking the Bonds: Non-viral Vectors Become Chemically Dynamic
Molecular Therapy (2008)
-
Polyphosphoramidate gene carriers: effect of charge group on gene transfer efficiency
Gene Therapy (2004)
-
CNS gene transfer mediated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA: a comparison with polyethylenimine/DNA complexes
Gene Therapy (2004)